Systemic quinolones and risk of acute liver failure I: Analysis of data from the US FDA adverse event reporting system

Systemic quinolones and risk of acute liver failure I: Analysis of data from the US FDA adverse event reporting system

Abstract Background and Aim Quinolones are a potent and globally popular group of antibiotics that are used to treat a wide range of infections. Some case reports have raised concern about their possible association with acute hepatic failure (AHF). Data from the US FDA Adverse Event Reporting Syste...

Full description

Bibliographic Details
Main Authors: Mohamed Kadry Taher, Abdallah Alami, Christopher A. Gravel, Derek Tsui, Lise M. Bjerre, Franco Momoli, Donald R. Mattison, Daniel Krewski
Format: Article
Language:English
Published: Wiley 2021-07-01
Series:JGH Open
Subjects:
acute hepatic failure
acute liver failure
FDA Adverse Event Reporting System
hepatotoxicity
quinolones
Online Access:https://doi.org/10.1002/jgh3.12585

Internet

https://doi.org/10.1002/jgh3.12585

Similar Items